Used primarily as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of selective estrogen receptor modulators (SERMs). Its structural features enable effective binding interactions with hormone receptors, making it valuable in treatments for hormone-dependent conditions such as breast cancer and osteoporosis. Due to its cyclohexane and cyanophenyl moieties, it contributes to metabolic stability and target specificity in active drug compounds. It is also employed in research settings for structure-activity relationship (SAR) studies aimed at optimizing receptor affinity and reducing off-target effects in new therapeutic candidates.